Flamen P - Search Results

1

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I. Necib H, et al. Among authors: flamen p. J Nucl Med. 2011 Mar;52(3):354-61. doi: 10.2967/jnumed.110.080150. J Nucl Med. 2011. PMID: 21345787 Free article.

2

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L. Van Laere K, et al. Among authors: flamen p. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51. doi: 10.1007/s00259-004-1564-3. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309329

3

Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.

Garcia C, Flamen P. Garcia C, et al. Among authors: flamen p. Curr Opin Oncol. 2008 May;20(3):275-9. doi: 10.1097/CCO.0b013e3282faa0cb. Curr Opin Oncol. 2008. PMID: 18391626 Review.

4

Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.

Van den Eynde M, Flamen P, El Nakadi I, Liberale G, Delatte P, Larsimont D, Hendlisz A. Van den Eynde M, et al. Among authors: flamen p. Clin Nucl Med. 2008 Oct;33(10):697-9. doi: 10.1097/RLU.0b013e318184b9a0. Clin Nucl Med. 2008. PMID: 18806572 No abstract available.

5

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.

Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, Hendlisz A. Flamen P, et al. Phys Med Biol. 2008 Nov 21;53(22):6591-603. doi: 10.1088/0031-9155/53/22/019. Epub 2008 Oct 31. Phys Med Biol. 2008. PMID: 18978442

6

Functional imaging of head and neck cancers.

Emonts P, Bourgeois P, Lemort M, Flamen P. Emonts P, et al. Among authors: flamen p. Curr Opin Oncol. 2009 May;21(3):212-7. doi: 10.1097/cco.0b013e32832a2322. Curr Opin Oncol. 2009. PMID: 19370804 Review.

7

Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.

Huyge V, Garcia C, Vanderstappen A, Alexiou J, Gil T, Flamen P. Huyge V, et al. Among authors: flamen p. Clin Nucl Med. 2009 Jul;34(7):417-20. doi: 10.1097/RLU.0b013e3181a7d03c. Clin Nucl Med. 2009. PMID: 19542943

8

State of the art: radiolabeled microspheres treatment for liver malignancies.

Deleporte A, Flamen P, Hendlisz A. Deleporte A, et al. Among authors: flamen p. Expert Opin Pharmacother. 2010 Mar;11(4):579-86. doi: 10.1517/14656560903520916. Expert Opin Pharmacother. 2010. PMID: 20163269 Review.

9

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.

Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, De Keukeleire K, Verslype C, Defreyne L, Van Cutsem E, Delatte P, Delaunoit T, Personeni N, Paesmans M, Van Laethem JL, Flamen P. Hendlisz A, et al. Among authors: flamen p. J Clin Oncol. 2010 Aug 10;28(23):3687-94. doi: 10.1200/JCO.2010.28.5643. Epub 2010 Jun 21. J Clin Oncol. 2010. PMID: 20567019 Clinical Trial.

10

WITHDRAWN:New PET imaging agents in the management of solid cancers.

Garcia C, Gebhart G, Flamen P. Garcia C, et al. Among authors: flamen p. Curr Opin Oncol. 2012 Mar 23. doi: 10.1097/CCO.0b013e3283528116. Online ahead of print. Curr Opin Oncol. 2012. PMID: 22410459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters